| Glenn Levine, MD | |
|
2801 Atlantic Ave, 3rd Floor, Long Beach, CA 90806-1701 | |
| (562) 933-8743 | |
| (562) 933-8014 |
| Full Name | Glenn Levine |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 2801 Atlantic Ave, Long Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003927195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | A71119 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Glenn Levine, MD 2801 Atlantic Ave, 3rd Floor, Long Beach, CA 90806-1701 Ph: (562) 933-8743 | Glenn Levine, MD 2801 Atlantic Ave, 3rd Floor, Long Beach, CA 90806-1701 Ph: (562) 933-8743 |
News Archive
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
With the federal government trying to cut costs and crack down on fraud, a congressional panel this week will set its sights on the Medicaid program, which last year paid out nearly $22 billion in error or fraudulent claims. The April 25 hearing by the House Oversight and Government Reform Committee is just the latest in a series that Congress has held recently targeting federal program that have high "error rates" in payments, such as Medicaid.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
A new study published on the preprint server bioRxiv* in June 2020 shows the potential of a new fusion molecule called a biparatopic protein to inhibit viral interaction with the host cell ACE2 receptor. This could lead to therapeutic applications.
› Verified 6 days ago
Dr. David C Kim, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2801 Atlantic Ave, Long Beach, CA 90806 Phone: 562-933-8100 | |
Sunita Ravinder Idnani, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1703 Termino Ave, Suite 206, Long Beach, CA 90804 Phone: 562-961-0210 Fax: 562-961-0212 | |
Barry Arthur Steinmetz, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 1760 Termino Ave, Suite 301, Long Beach, CA 90804 Phone: 562-933-3009 Fax: 562-933-8557 | |
Lorna Mcfarland, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3833 Worsham Ave # 301, Long Beach, CA 90808 Phone: 562-595-5479 Fax: 562-988-7616 | |
Tara Sutherland, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2650 Elm Ave Ste 301, Long Beach, CA 90806 Phone: 562-728-5034 | |
Richard Eric Swensson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2801 Atlantic Ave, Long Beach, CA 90806 Phone: 562-933-3350 Fax: 562-933-3359 |